MCM
RMD icon

Manchester Capital Management’s ResMed RMD Stock Holding History

Manchester Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
543
+16
+3% +$3.99K 0.02% 344
2025
Q4 		$127K Buy
527
+6
+1% +$1.53K 0.02% 332
2025
Q3 		$143K Sell
521
-12
-2% -$3.28K 0.02% 365
2025
Q2 		$138K Sell
533
-212
-28% -$50.6K 0.02% 405
2025
Q1 		$167K Buy
745
+28
+4% +$6.54K 0.02% 359
2024
Q4 		$164K Buy
717
+211
+42% +$50.8K 0.02% 363
2024
Q3 		$124K Buy
506
+15
+3% +$3.35K 0.01% 408
2024
Q2 		$94K Buy
491
+14
+3% +$2.84K 0.01% 425
2024
Q1 		$94.5K Buy
477
+9
+2% +$1.65K 0.01% 411
2023
Q4 		$80.5K Buy
468
+50
+12% +$7.68K 0.01% 375
2023
Q3 		$61.8K Sell
418
-1,746
-81% -$316K 0.01% 393
2023
Q2 		$473K Sell
2,164
-561
-21% -$125K 0.06% 178
2023
Q1 		$597K Buy
2,725
+289
+12% +$62.7K 0.08% 160
2022
Q4 		$507K Buy
2,436
+2,428
+30,350% +$533K 0.07% 156
2022
Q3 		$2K Hold
8
– – ﹤0.01% 680
2022
Q2 		$2K Buy
8
+2
+33% +$426 ﹤0.01% 733
2022
Q1 		$1K Hold
6
– – ﹤0.01% 970
2021
Q4 		$2K Sell
6
-2
-25% -$519 ﹤0.01% 867
2021
Q3 		$2K Buy
+8
New +$2.19K ﹤0.01% 882
2021
Q1 		– Sell
-14
Closed -$3K – 758
2020
Q4 		$3K Buy
14
+8
+133% +$1.59K ﹤0.01% 579
2020
Q3 		$1K Buy
+6
New +$1.11K ﹤0.01% 521
2015
Q1 		– Sell
-4,685
Closed -$263K – 809
2014
Q4 		$263K Hold
4,685
– – 0.03% 295
2014
Q3 		$231K Hold
4,685
– – 0.03% 315
2014
Q2 		$237K Hold
4,685
– – 0.03% 324
2014
Q1 		$209K Sell
4,685
-250
-5% -$11.2K 0.03% 330
2013
Q4 		$232K Hold
4,935
– – 0.04% 299
2013
Q3 		$261K Hold
4,935
– – 0.04% 274
2013
Q2 		$223K Buy
+4,935
New +$234K 0.04% 280

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Manchester Capital Management's RMD Position: Q1 2026 in Review

Manchester Capital Management increased its ResMed (RMD) stake by 3% in Q1 2026, buying an estimated $3.99K and bringing the position to 543 shares worth $122K. The position accounts for 0.02% of the portfolio, ranked #344.

Manchester Capital Management first reported a position in RMD in Q2 2013 and has held it in 28 quarters since. The position peaked at $597K in Q1 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Manchester Capital Management held 543 shares of ResMed worth $122K as of Q1 2026.
  • Manchester Capital Management bought 16 ResMed shares in Q1 2026, an estimated $3.99K.
  • ResMed made up 0.02% of Manchester Capital Management's portfolio in Q1 2026, its #344 holding.
  • Manchester Capital Management first reported a position in ResMed in Q2 2013 and has held it in 28 quarters since.
  • Manchester Capital Management's ResMed position peaked at $597K in Q1 2023.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.